Veterinary pharmaceutical companies are focusing on the development of advanced therapeutics to treat and prevent the spread of canine influenza. Vaccines, antiviral medications, and supportive ...
A further opportunity for product differentiation is the influenza vaccine manufacturing process. With the exception of Novartis's Madin–Darby canine kidney (MDCK) cell-based vaccine Optaflu ...
Around the same time, a senior in Louisiana was diagnosed with the first "severe" case in the U.S. As bird flu continues to ramp up, many are wondering what tools—namely, vaccines—we have to ...
H5 Influenza Vaccines: What Needs to Be Done to Reduce the Risk of a Pandemic Sep. 4, 2024 — As the global threat of H5N1 influenza looms with outbreaks across species and continents including ...
Improving vaccine uptake in children may reduce influenza illness and, subsequently, emergency department and hospital visits in a time of increased respiratory virus co-circulation. HealthDay ...
Stanford University researchers have developed a way to make the seasonal flu vaccine stronger against more strains, potentially including those that cause bird flu, the university said this month.
Among children of all ages, receiving at least 1 influenza vaccine dose was estimated to have a vaccine effectiveness of 55.7% for preventing influenza-associated emergency department visits or ...
The estimated effectiveness of at least one dose of the influenza vaccine against emergency department (ED) visits or hospitalization was over 50% across disease severity levels among nearly 16,000 US ...
The flu shot is the best protection against seasonal flu. This is why millions of people get the influenza vaccine each year. According to the World Health Organization, the seasonal flu infects up to ...
The first influenza vaccine was a monovalent live-attenuated vaccine, which was used in Russia until recently. In 1940, a second strain of influenza virus was isolated; this was named influenza B ...
CureVac and partner GSK are, meanwhile, also developing an mRNA-based flu vaccine, but are a little further back in development, as their shot is in phase 1 testing.